View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
LUCIER GREGORY T
(Last) (First) (Middle)
13320 BALLANTYNE CORPORATE PLACE
(Street)
CHARLOTTE NC 28277
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/23/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/23/2019 P 10,000 A $53.6047(1) 10,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.52 to $53.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Dane Baumgardner, attorney-in-fact for Gregory T. Lucier 05/23/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
               DENTSPLY SIRONA Inc.
Limited Power of Attorney for Section 16 Reporting
                    Obligations

Know all by these presents that the undersigned
hereby constitutes and appoints each of Keith
Ebling, and Dane Baumgardner, or either of them
acting singly and with full power of substitution,
the undersigned's true and lawful attorney-in-fact
to:

       1. Execute for and on behalf of the
undersigned, in the undersigned's capacity as an
officer or director or both of DENTSPLY SIRONA Inc.
(the "Company"), Forms 3, 4 and 5 (and any
amendments thereto) in accordance with Section
16(a) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and the rules
thereunder;

       2. To perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Forms 3,
4 or 5, complete and execute any amendments
thereto, and timely file such forms with the U.S.
Securities and Exchange Commission (the "SEC") and
any securities exchange or similar authority,
including without limitation the filing of a Form
ID or any other documents necessary or appropriate
to enable the undersigned to file the Forms 3, 4
and 5 electronically with the SEC;

       3. Seek or obtain, as the undersigned's
representative and on the undersigned's behalf,
information on transactions in the Company's
securities from any third party, including brokers,
employee benefit plan administrators and trustees,
and the undersigned hereby authorizes any such
person to release any such information to each of
the undersigned's attorneys-in-fact appointed by
this Limited Power of Attorney and approves and
ratifies any such release of information;

       4. Take any other action in connection with
the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best
interest of, or legally required by or for, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Limited Power of
Attorney shall be in such form and shall contain
such information and disclosure as such attorney-
in-fact may approve in such attorney-in-fact's
discretion.

	The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
required, necessary or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as
the undersigned might or could do if personally
present, with full power of substitution or
revocation, hereby ratifying and confirming all
that such attorney-in-fact, or such attorney-in-
fact's substitute or substitutes, shall lawfully do
or cause to be done by virtue of this Limited Power
of Attorney and the rights and powers herein
granted.

           The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such
capacity at the request and on the behalf of the
undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities
to comply with, or any liability for the failure to
comply with, any provision of Section 16 of the
Exchange Act.
           This Limited Power of Attorney shall
remain in full force and effect until the
undersigned is no longer required to file Forms 3,
4 or 5 with respect to the undersigned's holdings
of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned
in a signed writing delivered to the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed
this Limited Power of Attorney as of this 22nd day
of May 2019.

Signed and acknowledged:



/s/
Gregory T. Lucier